DTaP-IPV vaccine
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Inactivated poliovirus vaccine | Vaccine |
| Clinical data | |
| Trade names | Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others |
| AHFS/Drugs.com | Kinrix Quadracel |
| Routes of administration | Intramuscular injection |
| ATC code | |
DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine.[1] It is also known as DTaP/IPV or dTaP/IPV or DTPa-IPV. It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.
Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[2] and Quadracel from Sanofi Pasteur.[3]
References
- ^ "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
- ^ "Kinrix". US Food and Drug Administration. Retrieved 15 July 2018.
- ^ "Quadracel". US Food and Drug Administration. Retrieved 15 July 2018.
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |